Dechert LLP assisted Bryan Garnier & Co Ltd, as global coordinator, joint lead-manager and bookrunner, and RBC Europe Limited, as joint lead-manager and bookrunner, in relation to the €16 million public offering of Biom’Up. Biom’Up is a French company that specializes in surgical hemostasis. Its flagship product aims at simplifying surgical procedures in numerous specialties.

The team advising Bryan Garnier & Co Ltd and RBC Europe Limited included Paris-based corporate partner François Hellot and corporate associates Quentin Durand and Benhouda Derradji on corporate aspects, as well as New York-based corporate partner David Rosenthal on U.S. law. 

Biom’Up was advised by Orrick Rambaud Martel, led by partner Etienne Boursican and associate Alexandre Zuber.